These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 21756998)

  • 1. Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer's disease.
    Blalock EM; Buechel HM; Popovic J; Geddes JW; Landfield PW
    J Chem Neuroanat; 2011 Oct; 42(2):118-26. PubMed ID: 21756998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses.
    Blalock EM; Geddes JW; Chen KC; Porter NM; Markesbery WR; Landfield PW
    Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2173-8. PubMed ID: 14769913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression levels assessed by CA1 pyramidal neuron and regional hippocampal dissections in Alzheimer's disease.
    Ginsberg SD; Alldred MJ; Che S
    Neurobiol Dis; 2012 Jan; 45(1):99-107. PubMed ID: 21821124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective decline of neurotrophin and neurotrophin receptor genes within CA1 pyramidal neurons and hippocampus proper: Correlation with cognitive performance and neuropathology in mild cognitive impairment and Alzheimer's disease.
    Ginsberg SD; Malek-Ahmadi MH; Alldred MJ; Che S; Elarova I; Chen Y; Jeanneteau F; Kranz TM; Chao MV; Counts SE; Mufson EJ
    Hippocampus; 2019 May; 29(5):422-439. PubMed ID: 28888073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression.
    Ginsberg SD; Alldred MJ; Counts SE; Cataldo AM; Neve RL; Jiang Y; Wuu J; Chao MV; Mufson EJ; Nixon RA; Che S
    Biol Psychiatry; 2010 Nov; 68(10):885-93. PubMed ID: 20655510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant Hippocampal Functional Connectivity Is Associated with Fornix White Matter Integrity in Alzheimer's Disease and Mild Cognitive Impairment.
    Wang P; Zhou B; Yao H; Xie S; Feng F; Zhang Z; Guo Y; An N; Zhou Y; Zhang X; Liu Y
    J Alzheimers Dis; 2020; 75(4):1153-1168. PubMed ID: 32390630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal degeneration is associated with temporal and limbic gray matter/white matter tissue contrast in Alzheimer's disease.
    Salat DH; Chen JJ; van der Kouwe AJ; Greve DN; Fischl B; Rosas HD
    Neuroimage; 2011 Feb; 54(3):1795-802. PubMed ID: 20965261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling.
    Colangelo V; Schurr J; Ball MJ; Pelaez RP; Bazan NG; Lukiw WJ
    J Neurosci Res; 2002 Nov; 70(3):462-73. PubMed ID: 12391607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomic analysis reveals sex-specific patterns in the hippocampus in Alzheimer's disease.
    Onisiforou A; Christodoulou CC; Zamba-Papanicolaou E; Zanos P; Georgiou P
    Front Endocrinol (Lausanne); 2024; 15():1345498. PubMed ID: 38689734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer's disease neurofibrillary and beta-amyloid pathologies.
    Kelliher M; Fastbom J; Cowburn RF; Bonkale W; Ohm TG; Ravid R; Sorrentino V; O'Neill C
    Neuroscience; 1999; 92(2):499-513. PubMed ID: 10408600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer's disease.
    Elkahloun AG; Hafko R; Saavedra JM
    Alzheimers Res Ther; 2016 Jan; 8():5. PubMed ID: 26822027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gray and white matter degeneration revealed by diffusion in an Alzheimer mouse model.
    Zerbi V; Kleinnijenhuis M; Fang X; Jansen D; Veltien A; Van Asten J; Timmer N; Dederen PJ; Kiliaan AJ; Heerschap A
    Neurobiol Aging; 2013 May; 34(5):1440-50. PubMed ID: 23273575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippocampal lipid differences in Alzheimer's disease: a human brain study using matrix-assisted laser desorption/ionization-imaging mass spectrometry.
    Mendis LH; Grey AC; Faull RL; Curtis MA
    Brain Behav; 2016 Oct; 6(10):e00517. PubMed ID: 27781133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's-linked axonal changes accompany elevated antidromic action potential failure rate in aged mice.
    Russo ML; Ayala G; Neal D; Rogalsky AE; Ahmad S; Musial TF; Pearlman M; Bean LA; Farooqi AK; Ahmed A; Castaneda A; Patel A; Parduhn Z; Haddad LG; Gabriel A; Disterhoft JF; Nicholson DA
    Brain Res; 2024 Oct; 1841():149083. PubMed ID: 38866308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin messenger RNA-containing neurons in Alzheimer's disease: an in situ hybridization study in hippocampus, parahippocampal cortex and frontal cortex.
    Dournaud P; Cervera-Pierot P; Hirsch E; Javoy-Agid F; Kordon C; Agid Y; Epelbaum J
    Neuroscience; 1994 Aug; 61(4):755-64. PubMed ID: 7838375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter.
    Wang WX; Huang Q; Hu Y; Stromberg AJ; Nelson PT
    Acta Neuropathol; 2011 Feb; 121(2):193-205. PubMed ID: 20936480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topographic regulation of kinase activity in Alzheimer's disease brains.
    Grant P; Pant HC
    J Alzheimers Dis; 2002 Aug; 4(4):269-81. PubMed ID: 12446929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
    Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
    J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of microdissected neurons by 18O mass spectrometry reveals altered protein expression in Alzheimer's disease.
    Hashimoto M; Bogdanovic N; Nakagawa H; Volkmann I; Aoki M; Winblad B; Sakai J; Tjernberg LO
    J Cell Mol Med; 2012 Aug; 16(8):1686-700. PubMed ID: 21883897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White matter pathology isolates the hippocampal formation in Alzheimer's disease.
    Salat DH; Tuch DS; van der Kouwe AJ; Greve DN; Pappu V; Lee SY; Hevelone ND; Zaleta AK; Growdon JH; Corkin S; Fischl B; Rosas HD
    Neurobiol Aging; 2010 Feb; 31(2):244-56. PubMed ID: 18455835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.